Agoracom Blog Home

Archive for the ‘Medical Marijuana Stocks’ Category

« Older Entries
Newer Entries »

Enertopia Provides Shareholder Update

Posted by AGORACOM-JC at 6:08 PM on Friday, February 6th, 2015

VANCOUVER, BC / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) is pleased to announce the imminent launch of a brand new business initiative in the alternative health and wellness sector. We expect to be able to provide full details of our exciting product launch prior to market open on Monday, February 9th. However, we would like to provide some initial information on this exciting development, as well as an update on our Burlington, Ontario medical marihuana license application.

We recognize the challenges in the Canadian medical marihuana marijuana sector that have arisen in the past year due to evolving regulations and court challenges to just name a couple. Enertopia was the first public company in Canada to originally announce its intention to participate in the medical marihuana marijuana sector, in November of 2013. We have always tried to create value for our shareholders and those efforts continue.

In a timely and prudent fashion we expect to launch cannabidiol (CBD) – infused products, sourced from industrial hemp, in those jurisdictions where it is legal to do so. Those products are not currently legal under federal law in Canada, but they are legal in all 50 states in the USA. We hope, one day, to be able to grow medical marihuana under license and to be a vertically integrated company also using our knowledge and raw materials to manufacture CBD-infused products.

Next week we will announce our first new product for distribution in Canada. It will not contain any CBD’s. It is within a rapidly growing exciting alternative health and wellness sector that is receiving a great deal of attention. We intend to build this business by establishing our sales force and retail distribution by developing marketing and advertising materials to help us build our brand image.

We hope to introduce that same product, and subsequently a similar product infused with CBD’s, into the US markets later in 2015. These marketing and branding initiatives will help us to build our sales channels for broader product offerings over time. We believe these efforts will help us to build significant shareholder value while we go through the lengthy MMPR licence granting process.

Enertopia wishes to inform all stakeholders that it continues to pursue its Health Canada MMPR licensed producer status by way of its current joint venture partners. Both the Company and our shareholders have realized that the time required to move through the licensing process have been extended due to the two pending court cases, the first of which is to be heard on February 23, 2015.

Enertopia is fully committed to growing the Company and delivering value for future customers, employees and shareholders.

On February 6, 2015, the Enertopia’s Board has appointed Ms. Bal Bhullar as a Director of the Company. She has and continues to be the Chief Financial Officer since October 9, 2009.

The Board has also accepted the resignation from Mr. John Thomas as a Director of Enertopia.

“I am happy to have MS. Bhullar join our board of Directors as she has been a dedicated officer to Enertopia since becoming CFO in October, 2009. I wish John all the best in his future business endeavours and thank him for his past efforts. As we move forward in 2015 I look forward to building out the Enertopia board for future growth in providing healing and wellness opportunities to a growing percentage of the population.” Stated President Robert McAllister

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Robert McAllister, the President: (250) 765-6412

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation and sale of sexual creams and other items, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the new business initiative will have any meaningful impact on the Company or the Company will be able to obtain future financings or a license under the MMPR program.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , ,
Posted in Enertopia, Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Provides Shareholder Update

Lexaria Updates Operations

Posted by AGORACOM-JC at 9:45 AM on Wednesday, February 4th, 2015

KELOWNA, BC / February 4, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) provides the following three operational updates.

CREDIT CARDS

Lexaria is pleased to announce it is now accepting Mastercard and Visa credit card payments at its www.vipova.com e-commerce site for sales of its patent-pending CBD-infused black tea across America. Previously, customers could only transact with the ViPova website with checks and money orders, and while these payment options remain for those who prefer them, Vipova’s ability to accept major credit cards will shorten delivery times and provide the ease of ordering that customers expect.

Given the increase in web traffic Vipova.com has experienced, Lexaria believes the ability to use credit cards should lead to an increase in sales volumes. Customers across the US can also call 1-888-976-8482 from 9AM to 7PM EST Mon-Fri to place their orders.

FOCUS GROUPS

Lexaria has begun holding focus group sessions to introduce and evaluate its CBD-infused black tea. Our first focus group was held January 29 when 14 people were introduced to ViPova Tea. The session provided a chance for potential consumers to learn about the tea and the properties of cannabidiol infusion, and proved immensely valuable to the Company to learn about consumer preferences, needs, likes and dislikes.

Lexaria is very pleased at the enthusiastic response and comments received. Participants had the opportunity to meet senior representatives of ViPova, and provide detailed commentary that the Company will use to fine-tune its products and marketing as 2015 unfolds.

The next focus group will be held during the next several days and the Company expects to continue to hold similar focus group meetings in the weeks and months to come.

STRATEGIC ADVISOR

Lexaria has engaged Sequoia Partners Inc for strategic fiscal advisement and for the development of various strategies to assist the Company to realize its project objectives. Lexaria will be working closely with the Managing Partners of Sequoia to pursue its interests. The Managing Partners have extensive and long lasting relationships in the finance, health care and pharmaceutical industries that are expected to be beneficial to the Company.

Sequoia has been granted 250,000 stock options and will receive a monthly fee of CDN$5,000 for the next six months.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns. www.lexariaenergy.com.

About ViPova(TM)

ViPova(TM) uses only legal CBD oil extracts, grown from legal hemp in locations where it is legal to do so, in ViPova(TM)-branded tea. ViPova(TM) uses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPova(TM) has this ground-breaking technology for CBD/lipid infusion. www.vipova.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate”, “if”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “could”, “should”, “will”, and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that any cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPova(TM) products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Tags: , , , , , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Updates Operations

Lexaria Maintains OTCQB Marketplace Status

Posted by AGORACOM-JC at 1:28 PM on Monday, February 2nd, 2015

KELOWNA, BC / February 2, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) announces the Company has submitted all the mandatory documents and has successfully met all of the requirements for continued listing and trading on the OTCQB Marketplace. Partly as a result of this, Realtime Level II Quote Display Service is now available to investors free at www.otcmarkets.com/stock/LXRP/quote.

Lexaria is a US Company that trades in the USA on the OTCQB venture stage marketplace for early stage and developing U.S. and international companies. Companies listed at OTCQB are current in their reporting and undergo an annual verification and management certification process. Lexaria has continuously filed its quarterly and annual reports, and more, at the SEC “EDGAR” site since 2006.

Since 2009, Lexaria also has traded on the Canadian Securities Exchange in Canada, the fastest growing stock exchange in North America. Lexaria is eligible for registered retirement accounts for Canadian investors, is compliant with all CSE regulatory policies, and is Fully Reporting under Canadian securities laws.

Lexaria is pleased to continue its open and transparent communications and accessibility with its investors across North America and expects this tradition to continue in 2015 and beyond.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns. www.lexariaenergy.com/.

About ViPova(TM)

ViPova(TM)uses only legal CBD oil extracts, grown from legal hemp in locations where it is legal to do so, in ViPova(TM)-branded tea. ViPova(TM) uses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPova(TM) has this ground-breaking technology for CBD/lipid infusion. www.vipova.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate”, “if”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “could”, “should”, “will”, and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that any cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPova(TM) products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Maintains OTCQB Marketplace Status

Enertopia Closes First Tranche of Financing

Posted by AGORACOM-JC at 8:05 AM on Friday, January 30th, 2015

Vancouver, BC / Jaunuary 30, 2015 / Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce it has closed the first tranche of CAD$99,900 for its Private Placement announced on November 5, 2014. Enertopia will be issuing 1,665,000 common shares at CAD$0.06 and 1,665,000 whole warrants that expire on January 30, 2018 with an exercise price of US$0.10 during the first 24 months and US$0.15 after 24 months until they expire on January 30, 2018.

A cash finder’s fee for $7,358.40 and 122,640 full broker warrants that expire on January 30, 2018 with the same exercise terms as noted above was paid to arm’s length party.

All issued shares will be subject to a hold period, for any resale into the United States under Rule 144, of six months and one day. Proceeds of the Private Placement will be used for general working capital, for corporate opportunities in the Medical Marihuana and health and wellness industries. The Private Placement will be subject to normal regulatory approvals.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Robert McAllister, the President at 1.250.765.6412

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. There can be no assurance that the funds raised will have any positive impact on Enertopia. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Closes First Tranche of Financing

Legal Marijuana is Now the Fastest Growing Industry in America

Posted by AGORACOM-JC at 1:16 PM on Tuesday, January 27th, 2015

Legal Marijuana is Now the Fastest Growing Industry in America

Indulging in the green is no longer just a cocktail conversation – it’s big business.

According to researchers from cannabis industry investment and research firm The ArcView Group, the legal marijuana market in the United States ballooned to $2.7 billion last year, growing 74 per cent from 2013 to become the fastest-growing industry in the nation.

That’s a lot of weed sales – and a major boost to the economy business leaders are all of a sudden taking very seriously.

Just ask former US Senator Mike Gravel.

What’s especially impressive is only four states have legalized adult cannabis use and sales, with another eight expected to jump on board by the end of next year.

If legalization is eventually enacted across all 50 states, the legal marijuana industry is projected to become larger than the organic food industry.

And while the U.S. is blazing the trail, we can probably expect a budding cannabis business to boost Canada’s GDP in the near future – Trudeau 2015, anyone? After all, everything that happens in the U.S. eventually becomes big North of the Border.

Who would have guessed that the most effective recovery from the next recession could be to smoke ourselves out?

Certainly not what we learned in economics class.

#NOTABLE

Want more updates on the most Notable things happening so you know before your colleagues do? Get our exclusive newsletter here and follow us on Twitter for all the latest.

Source: http://notable.ca/nationwide/yp-life/Legal-Marijuana-is-Now-the-Fastest-Growing-Industry-in-America/

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Legal Marijuana is Now the Fastest Growing Industry in America

Lexaria Announces ViPovaTM Website for CBD Research and Direct Tea Sales

Posted by AGORACOM-JC at 9:46 AM on Thursday, January 15th, 2015

KELOWNA, BC / January 15, 2015 / Lexaria, Corp. (LXRP) (CSE:LXX) (the “Company”) announces that ViPova(TM) by Lexaria has launched a new website at www.vipova.com. The new site is live and contains research on tea, cannabinoids (CBD) and cannabidiol.

Consumers across all 50 states can now buy America’s FIRST product that uses patent-pending technology to infuse CBDs within lipids for the most comforting and effective experience possible.

The new www.vipova.com website will take your orders now and we have ViPova(TM) Tea in-stock and ready to ship today. Customers can also call 1-888-976-8482 from 9AM to 7PM EST Mon-Fri to place their orders. We are not yet ready to accept credit cards as payment, but expect to be able to add that feature soon.

For a limited time only, we have two introductory offers to thank our first customers:

Our earliest customers will receive a coupon with their first order of ViPova(TM) Tea; the coupon is good for 30% off your second order, and your second order can be any size you like. Only one coupon will be available to each customer. Also for a limited time, get free shipping anywhere in the USA for your tea order – we pay the cost of delivering the tea to you. www.vipova.com is more than just the first online location to sell ViPova(TM) Tea. It is also a leading location for research on cannabinoids, allowing visitors to learn for themselves of the many studies already conducted on CBD’s. Research will be regularly updated and broadened and everyone is encouraged to visit to learn of the wondrous properties of cannabidiol.

We also are launching an online community and blog at the website; users will have the opportunity to share their personal experiences with the therapeutic and wellness effects of cannabinoids and customer experiences with ViPova Tea. Over time we hope that users will share knowledge, recipes and other information.

As well, ViPova(TM) co-founder and consultant to Lexaria Dr. Michelle Reillo, will write a regular blog feature available only at www.vipova.com, sharing her extensive knowledge on the endocannabinoid system and how her research has suggesting that good overall health is perhaps not possible when the endocannabinoid system is compromised or weakened.

It is our hope that over time, www.vipova.com will become the leading portal for knowledge, research, personal experiences and, of course, a venue to purchase products from Vipova(TM) all related to cannabinoids.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns. www.lexariaenergy.com

About ViPova(TM)

ViPova(TM) uses only legal CBD oil extracts, grown from legal hemp in locations where it is legal to do so, in ViPova(TM)-branded tea. ViPova(TM) uses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPova(TM) has this ground-breaking technology for CBD/lipid infusion. www.vipova.com

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate”, “if”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “could”, “should”, “will”, and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that any cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPova(TM) products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Announces ViPovaTM Website for CBD Research and Direct Tea Sales

Lexaria Commissions Cannabinoid Education Series

Posted by AGORACOM-JC at 8:19 AM on Thursday, January 8th, 2015

Kelowna, British Columbia–(January 8, 2015) – Lexaria, Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) has engaged Michelle Reillo, PhD, to write a series of manuals providing guidance to both consumers of CBD and practitioners who advise patients in their use of CBD. This wide ranging series will offer guidance and instruction as to how to maximize performance, health, and wellness through the proper and regimented consumption of Cannabidiol.

Lexaria recognizes there is an enormous information vacuum with respect to cannabidiol (CBD), its usage, and the health benefits it provides. For those who wish to immediately learn more, we refer you to the beta version of our www.vipova.com website where you can find the US Government’s patent on cannabidiol, Patent # 6630507, which provides a broad overview of the health benefits associated with CBD.

The Lexaria education series will address how the human endocannabinoid system functions as the body’s circuit board, essentially connecting and regulating all of the major systems in the body. These include the immune system, the cardiovascular system, central nervous system, and gastrointestinal system. A properly functioning endocannabinoid system relies on having enough natural cannabinoids coursing through the bloodstream to bind with the body’s cannabinoid receptors.

As humans age, however, the natural cannabinoids upon which everyone relies for good health materially deplete. When this occurs, the cannabinoid receptors have nothing with which to bind, causing imbalances in the body. These imbalances are a primary cause of the aches, pains, and illness people suffer as they age. Cannabinoid levels can be restored, however, by the proper consumption of phytocannabinoids, such as those found in CBD oil.

This series will address the specific CBD needs of athletes, the aging, alcohol and nicotine users, caregivers, those suffering from chronic illness, and others. It will address how CBD helps the body’s physiology, how to optimize CBD consumption, and how to use CBD to potentially achieve certain health, wellness, and performance results.

Chris Bunka, CEO of Lexaria Corp said, “We are very excited to have Dr. Reillo write these education manuals on Lexaria’s behalf. The CBD industry is in its infancy, and the benefits of CBD consumption are only just now being understood. We believe that as a producer of CBD products, it is our obligation to make sure that our customers understand how to use our products to achieve the maximum health and performance benefits possible. Michelle is one of the foremost authorities and leading researchers on CBD in the world and we’re certain her work will benefit each of Lexaria’s customers.”

We remind all consumers that ViPovaTM uses only legal CBD oil extracts, grown from legal hemp in locations where it is legal to do so, in ViPovaTM-branded tea. ViPovaTM uses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPovaTM has this ground-breaking technology for CBD/lipid infusion.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that any cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Commissions Cannabinoid Education Series

CLIENT FEATURE: Lexaria (LXX: CSE) Application in Progress to Produce 10,000kg of Med Marijuana Per Year

Posted by AGORACOM-JC at 11:35 AM on Wednesday, January 7th, 2015

(LXX: CSE, LXRP: OTCQB)

Regulated Marijuana Production

  • Burlington joint venture approximately 75,000 sq ft in total potential space
  • Applied to produce 10,000kg of Medical Marijuana per year
  • Planned production areas have 22 foot ceilings which will allow for the possibility of a 2nd mezzanine level in many areas, allowing for additional future expansion.
  • Closed 51% acquisition of Poviva Tea, LLC

Gupta: ‘I am doubling down’ on medical marijuana


Dr. Sanjay Gupta, CNN Cheif Medical Correspondent. We have no affiliation with this well known medical expert, but his latest “Doubling Down” on the medical marijuana sector is worthy of your attention. Reasons such as these convince us we are doing the right thing in entering this market.

Medical marijuana and ‘the entourage effect’

Today, most Americans and most Canadians support some form of medical use of marijuana, in poll after poll.

Likewise, the legal marijuana industry is and will be heavily regulated, and we support that. We’ve already proven our ability to be transparent with our stakeholders and our ability to work within all applicable government regulations. We promise to deliver that transparency and dedication to the legal marijuana industry where these traits are a vital component towards ultimate success.


The medical marijuana business just might be one of the most recession-proof industry sectors there are. There is no boom and bust cycle that is apparent. The average demographic age in North America continues to increase, with over 44 million people in the USA today at the age of 65 or over. Age-related illnesses will continue to grow, and some fraction of these people looking for an alternative to opiate-based painkillers have a real need for pain-relief choices.

12 Month Stock Chart


Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Lexaria Corp., Medical Marijuana Stocks | Comments Off on CLIENT FEATURE: Lexaria (LXX: CSE) Application in Progress to Produce 10,000kg of Med Marijuana Per Year

Mazorro Announces Results of Meeting, Management Changes, and Effective Date of Name Change and Amalgamation

Posted by AGORACOM-JC at 8:40 AM on Wednesday, December 31st, 2014

OTTAWA, ONTARIO–(Dec. 31, 2014) – Mazorro Resources Inc. (the “Company“) (CSE:MZO) (FRANKFURT:JAM) is pleased to announce that the following matters were approved by the Company’s shareholders at the special meeting of shareholders held on December 29, 2014:

(i) a change of business from mineral resource exploration to the medical marijuana industry upon completion of the Company’s previously announced acquisition of GrowPros MMP Inc. (the “GrowPros Sub“) pursuant to a three-cornered amalgamation between the Company, its wholly-owned subsidiary 9048073 Canada Inc., and the GrowPros Sub (the “Amalgamation“);
(ii) a change of name to “GrowPros Cannabis Ventures Inc.” (the “Name Change“) upon completion of the Amalgamation; and
(iii) an amended fixed share option plan (the “Plan“), which increases the maximum number of common shares reserved for issuance under the Plan to 5,807,048, representing 10% of the number of issued and outstanding common shares of the Company upon completion of the Amalgamation.

The Amalgamation was previously approved by the shareholders of GrowPros Sub at a special meeting of its shareholders held on December 22, 2014.

The Company has now completed the necessary corporate filings and has received certificates of amalgamation and amendment confirming January 1, 2015 as the effective date of the Amalgamation and the Name Change (the “Effective Date“). The Company expects to begin trading on the Canadian Securities Exchange (the “CSE“) under its new name and new trading symbol “GCI” on or about January 5, 2015, subject to the filing of all required documentation with the CSE. The new CUSIP and ISIN numbers for the Company’s common shares will be 39985Y102 and CA39985Y1025.

As of the Effective Date, the issued and outstanding capital of the Company will consist of 58,070,487 common shares, 15,463,000 common share purchase warrants, 501,300 agent compensation options, and 1,225,000 stock options.

The Company is further pleased to confirm, as previously announced, that as of the Effective Date, Mr. Ryan Brown will join the Company’s board of directors and will be appointed as the Company’s new President and CEO and Mr. Sabino Di Paola will be appointed as the Company’s new CFO and Corporate Secretary. Mr. Brown will be replacing Mr. Léo Côté, who will be resigning from the Company’s board of directors, and Messrs. Brown and Di Paola will assume the senior officer roles currently held by Mr. André Audet who will remain on the board of directors as Chairman but will resign as the Company’s Interim President, CEO, and CFO.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to complete the Amalgamation and Change of Business, failure to obtain sufficient financing, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Any forward-looking statement speaks only as of the date on which it is made and except as may be required by applicable securities laws. The Company disclaims any intent or obligation to update any forward-looking statement.

Andre Audet
Director
Phone: (613) 241-2332

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in GrowPros Cannabis Inc., Medical Marijuana Stocks | Comments Off on Mazorro Announces Results of Meeting, Management Changes, and Effective Date of Name Change and Amalgamation

ViPova(TM) by Lexaria Announces New President

Posted by AGORACOM-JC at 8:00 AM on Monday, December 22nd, 2014

KELOWNA, BC / December 22 , 2015 / Lexaria, Corp. (LXRP) (CSE:LXX) (the “Company”), as part of its broader business transition into the alternative health industry, is pleased to announce it has hired Tom Ihrke as President of its U.S. subsidiary to oversee the rollout and sale of its ViPova(TM) brand, CBD infused teas. Lexaria has also named Tom as Executive Vice President of U.S. Operations of Lexaria Corp.

Tom has been working with Lexaria as a part time consultant over the last eight years. Tom’s extensive experience investing in and advising small companies will prove extremely valuable to Lexaria as it enters the exciting and fast growing alternative health industry. In addition to advising Lexaria with its business strategy and capital market activities Tom will oversee all aspects of the ViPova Brand, including the day to day business, operations, sales and marketing. The company’s goal is to develop internationally recognized lines of healthy food and beverage products, initially focusing on tea and coffee.

“I’m very pleased to welcome Tom to our executive management team. He is a highly skilled and effective manager who is clearly able to take ViPova(TM) to another level, and help us as we expand our brands and offerings in the CBD sector,” said Chris Bunka, CEO of Lexaria Corp.

ViPova(TM) uses only legal CBD oil extracts, grown from legal hemp in locations where it is legal to do so, in ViPova(TM)-branded tea. ViPova(TM) uses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPova(TM) has this ground-breaking technology for CBD/lipid infusion.

As well, Lexaria announces it has granted a total of 1,425,000 stock options to a number of executives, directors and consulting employees, all priced at US$0.11. The Company makes note that 850,000 existing options are due to expire on January 20, 2015 unless exercised before then.

All issued shares will be subject to a hold period, for any resale into the USA under Rule 144, of six months and one day. The share issuance is subject to normal regulatory approvals. The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria:
Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

Contact:
Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

Forward-Looking Statement:
This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that any cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPova(TM) products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Source: Lexaria Corp.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on ViPova(TM) by Lexaria Announces New President

« Older Entries
Newer Entries »